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Adult T-cell leukemia/lymphoma (ATLL), a T-cell neoplasm
caused by human T-cell lymphotropic virus type 1 (HTLV-1),
develops in the majority of cases in individuals who were in-
fected with HTLV-1 as young children, by their mother during
prolonged breastfeeding. We report the case of a Caucasian
French man, whose parents were HTLV-1-seronegative and
who developed ATLL after HTLV-1 sexual transmission
by a Cameroonian woman. This hypothesis was corroborated
by genotyping of the patient’s virus, which revealed an
HTLV-1B strain, found only in Central Africa, especially in
Cameroon. Thus, ATLL may develop after HTLV-1 infection
during adulthood, outside breastfeeding.
Keywords. ATLL; HTLV-1; HTLV-1 transmission; lymphoma;
viral genotyping.
Adult T-cell leukemia/lymphoma (ATLL) is an aggressive T-cell
lymphoproliferation caused by human T-cell lymphotropic
virus type 1 (HTLV-1) [1, 2]. This oncogenic human retrovirus
can be acquired by mother-to-child transmission through
prolonged breastfeeding, sexual transmission, or from trans-
fused infected blood cells or intravenous (IV) drug abuse [2].
Human T-cell lymphotropic virus type 1 infects at least 5–10
million individuals worldwide and, among them, 1%–5% will
develop ATLL during their lifetime [3]. The results of several
studies showed that most cases of ATLL develop in individuals
who have been infected with HTLV-1 as young children via
their mothers’ breast milk [4–7]. The very rare ATLL cases ob-
served after transfusion or sexual transmission are still being de-
bated [8–11]. In this study, we report on a Caucasian French
patient, with HTLV-1-seronegative parents, who developed
ATLL 18 years after highly probable sexual transmission
of HTLV-1 through repeated unprotected sexual intercourse
with a Cameroonian woman. Indeed, genotyping of the pa-
tient’s virus revealed infection with an HTLV-1 subtype-B
strain, typically of Central African origin, especially Cameroon.
This case definitively confirms the hypothesis that ATLL can
develop, albeit rarely, after infection during adulthood, outside
breastfeeding.
CASE REPORT
The patient’s written consent was obtained for this report. A 43-
year-old Caucasian French man was referred to our hospital in
2002 for cutaneous T-cell lymphoma (CTCL) associated with
positive HTLV-1 serology. The patient had no remarkable per-
sonal or family medical history. He was born and raised in
Mainland France, had no siblings, and was exclusively fed
with bottle milk during childhood. His current history had
begun 8 years earlier (1994) with the development of erythema-
tosquamous plaques on his ankles, with ascending evolution
over the next 5 years and progressive involvement of legs, but-
tocks, lumbar region, and axillary areas, affecting nearly 30% of
his body surface. Topical corticosteroids were applied initially
without formal diagnosis, with an initial response followed by
relapse. In 2001, 3 cutaneous nodular lesions (20–30 mm)
appeared at different sites (thigh, eyebrow, and leg), with necro-
tizing evolution and atrophic scaring. Physical examination re-
vealed no lymphadenopathy or hepatosplenomegaly.
A nodule was biopsed: a band-like mononuclear cell infiltrate
was seen in the upper dermis with markedly epidermotropic
large cells with indented nuclei (Figure 1A–C). Immuno-
labeling revealed the infiltrate to be mainly constituted by
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CD2+, CD3+, CD4+, CD5+, and CD25+ T cell, but not CD7 and
CD8. Molecular analysis showed clonal T-cell receptor (TCR)-γ
and β-gene rearrangements. Human T-cell lymphotropic virus
type 1 serology was positive by both immunofluorescence on
MT2 cells and particle-agglutination (PA) assays (Serodia
HTLV-1; Fujirebio Inc, Tokyo, Japan) and then confirmed by
Western blotting (HTLV Blot 2.4; MP Biomedicals Asia Pacific
Pte. Ltd, Singapore), with typical complete seroreactivity (p19,
p24, pr53, GD21, and MTA-1). Anti-HTLV-1 antibody titers,
determined by serial dilution, were 1/10 240 on MT2 cells
and 1/2048 in the PA assay. A circulating HTLV-1 provirus
load determined by quantitative polymerase chain reaction
(PCR) was relatively high: 18.6 copies/100 peripheral blood
mononuclear cells (PBMCs). Complete blood count, especially
lymphocyte count, was normal; serum lactate dehydrogenase
and calcemia levels were within their normal ranges. The
blood smear showed 5% flower cells (Figure 1D). Flow cytomet-
ric immunophenotyping of circulating lymphocytes detected
8% CD2+, CD3+, CD4+, CD5+, CD7−, CD25+, and HLADR+
cells. T-cell clonality was demonstrated by the presence of a
TCR-γ gene rearrangement detectable by PCR analysis of
blood cells. This TCR-γ gene rearrangement was the same as
that found in the skin. Moreover, analysis of the HTLV-1 inte-
gration sites using inverse PCR demonstrated HTLV-1 clonal
population in PBMC DNA with identical clones over time
[12]. Bone marrow aspiration and trephine biopsy revealed
no malignant involvement. Human immunodeficiency virus
serology was negative, serum protein electrophoresis and im-
munoglobulins levels were normal, and antinuclear antibodies
were absent. There was no argument for an underlying immu-
nocompromised status. Thoracic, abdominal, and pelvic com-
puted-tomography scans showed no lymph node, liver, or
spleen enlargement, but it found multiple micronodular lesions
in the lungs. Therefore, according to the Shimoyama classifica-
tion, smouldering ATLL was diagnosed [1].
Treatment consisted of PUVA therapy followed by zidovu-
dine and interferon-alpha [13, 14]. Complete remission was
rapidly obtained. Zidovudine was discontinued in 2008 after 6
years of treatment due to persistent neutropenia and elevated
liver enzymes. Absolute neutrophil count and liver enzymes
subsequently normalized. At the last follow-up visit (2014),
the patient continued interferon-alpha and was in sustained
Figure 1. (A) Biopsy of a skin nodule showing parakeratosis surrounding acanthotic epidermis, with a band-like mononuclear cell infiltrate tending to gain
the epidermis, and (B) marked epidermotropism of large lymphocytes with hyperchromatic nuclei (A and B: hematoxylin and eosin, A × 100; B × 200). C, The
band-like epidermotropic infiltrate was strongly labeled with anti-CD3 antibody (×50). D, Blood smear morphology: atypical medium size lymphocyte with
agranular and weakly basophilic cytoplasm, condensed chromatin, and convoluted nucleus, designated a “flower cell” (May-Grünwald Giemsa, ×1000).
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complete remission. Blood analysis showed no TCR-γ gene
rearrangement.
Because both of his parents were Caucasian and HTLV-
1-seronegative (Abbott HTLV-I/HTLV-II EIA, Abbott Park,
Illinois), and the patient had no known risk factor for HTLV-
1 exposure through blood products or IV drug abuse, we
wondered about the route of infection. Sexual transmission of
HTLV-1 was considered the most likely, because the patient
had lived for 8 months with a Cameroonian woman with
whom he had repeated unprotected sexual intercourse during
a prolonged stay in Cameroon when he was 17 years old. The
hypothesis of sexual transmission was corroborated by the gen-
otyping of the virus isolated from the patient. Indeed, sequenc-
ing of a 758-base pair DNA fragment of the long terminal
repeat region extracted from 2 PBMCs samples (PH1512 and
PH1515) collected at a 7-year interval demonstrated that the
virus infecting this patient belonged to the Central African
subtype B (Figure 2). Pertinently, these HTLV-1 provirus strains
clustered (bootstrap value, 84) with 2 strains (PH236 and T49)
previously characterized in individuals of Cameroonian origin.
DISCUSSION
This patient originally consulted for a CTCL characterized by a
clonal skin proliferation of CD4+ and CD25+ cells, associated
with small percentages of those cells circulating in his blood.
Human T-cell lymphotropic virus type 1 infection was demon-
strated based on the strong specific seropositivity confirmed by
Western blotting and detection of the HTLV-1 genome in the
blood. Inverse PCR also identified an HTLV-1 clonal popula-
tion in his blood. Taken together, those findings clearly demon-
strated that our patient suffered from smouldering ATLL. Adult
T-cell leukemia/lymphoma is a mature T-cell malignancy
observed mainly in patients from high HTLV-1-endemic
Figure 2. Phylogenetic tree generated using the neighbor-joining (NJ) method on a 758-base pair (bp) fragment of the long terminal repeat (LTR) region
for available sequences of 38 human T-cell lymphotropic viruses type 1 (HTLV-1), including the 2 sequences generated in this study (boxed in bold type). The
HTLV-1 strains were aligned with the DAMBE program (version 4.2.13). The final alignment was subjected to the Model-test program (version 3.6) to select,
according to the Akaike information criterion, the best model to apply to phylogenetic analyses. The selected model was the General Time Reversible model.
Bootstrap values were calculated for 1000 replicates, and those values at some tree nodes indicate occurrence frequencies for 100 trees. Subtypes A–D are
the 4 major HTLV-1 subtypes. Subtype B corresponds to the Central African subtype including the PH1512 and PH1515 sequences generated herein.
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regions, eg, southwestern Japan, the Caribbean basin and South
America, sub-Saharan Africa, and localized areas of Iran and
Australo-Melanesia. Among HTLV-1-infected individuals
worldwide, only 1%–5% will develop ATLL during their life-
times, after a prolonged latency period (20–60 years), during
which sustained oligoclonal or polyclonal expansion of infected
T cells occurs, associated with a high level of genetic instability.
At the molecular level, HTLV-1 oncogenicity mainly depends
on the virus-encoded Tax oncoprotein. By interfering with ge-
nome repair, cell cycle, and apoptosis machinery, Tax plays key
roles in inducing clonal expansion and genetic instability of in-
fected cells, leading to early leukemogenesis. Recently, it was
shown that HTLV-1 bZIP factor, encoded by the minus strand
of the HTLV-1 provirus and constitutively detectable in ATLL,
could play a significant role in leukemogenesis and the mainte-
nance of leukemic clones [15]. Given its long latency period, in-
fection early in life is considered the main risk factor for ATLL,
although some cofactors, eg, coinfection with Strongyloides ster-
coralis [2] or an immunocompromised status, might also be
involved [9, 16–18]. Thus, in contrast to what is observed in
tropical spastic paraparesis/HTLV-1-associated myelopathy,
ATLL seems to develop only after mother-to-child transmis-
sion, and ATLL occurrence after sexual or blood transmission
remains highly controversial.
Molecular epidemiologic studies on HTLV-1 demonstrated
that, despite being a retrovirus, this oncogenic agent exhibits
marked genetic stability [19]. That property is very probably
linked to replication through clonal expansion of infected
cells, rather than using the error-prone reverse transcriptase.
Seven molecular genotypes linked to the geographic or ethnic
origin of the infected individual have been reported. They in-
clude the subtype A, also known as the cosmopolitan subtype,
which includes the prototype HTLV-1 sequence from Japan and
is found in many HTLV-1-endemic areas worldwide. The other
subtypes B, D, E, F, and G are found only in Central Africa, and
the subtype C is only found in Australo-Melanesia [3, 20]. The
very low genetic HTLV-1 drift in vivo associated with such ge-
notype geographic specificity can be used as a molecular means
to better understand ancient movements of infected popula-
tions but also to monitor virus transmission and trace the origin
of a virus in a given individual [19, 20]. The vast majority of
ATLL cases seen in Europe occur in patients of black ancestry
from the West Indies or West Africa. In almost all of those pa-
tients, the cosmopolitan subtype-A viral genotype is found.
Our main question was as follows: How did this Caucasian
patient with HTLV-1-seronegative parents acquire HTLV-1 in-
fection? The absence of blood transmission and the fact that the
patient had sexual intercourse over several months in Camer-
oon (a high HTLV-1-endemic area) strongly suggested that
the virus had been sexually acquired. Therefore, we performed
virus genotyping to strengthen this hypothesis. We found that
the patient was infected with a typical HTLV-1 strain of the
subtype B, a rare genotype, absent in Europe, and found only
in Central Africa, especially Cameroon.
CONCLUSIONS
This case demonstrates the occurrence of ATLL in a Caucasian
patient infected with an HTLV-1 subtype-B strain, found only
in Central Africa, and definitively confirms the hypothesis that
ATLL can develop after infection during adulthood, outside
breastfeeding, and especially after sexual transmission of
HTLV-1.
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